The clinical impact of 16S ribosomal RNA PCR and sequencing in the identification of bacterial infections: a 7-year report from a Lebanese tertiary care center
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1619640 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Nour Youssef und 14 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Diseases Research (CIDR) and World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Patho…. Hauptthemen laut MEDLINE: Bacterial Infections, RNA, Ribosomal, 16S, Bacteria, Polymerase Chain Reaction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
The identification of bacterial pathogens in the clinical setting is essential for providing optimal care and improving outcomes. The primary objective of this study was to assess the performance of the 16S test in bacterial identification from different samples and determine its impact on clinical outcomes.
Methods
This was a retrospective study of patient samples collected from all age-groups at the American University of Beirut Medical Center (AUBMC), from May 2016 to December 2022. Descriptive statistics were conducted to calculate the 16S test positivity rate and to describe the different types of organisms. Univariate analyses were performed to study the clinical impact of the 16S test and its comparison to the conventional bacterial culture among different characteristics. A p ≤ 0.05 was considered statistically significant.
Results
A total of 1489 specimens were submitted for the 16S test during the study period. Of the submitted tests, 395 (26%) had bacteria identified by the 16S test and/or culture. Out of the culture negative/16S positive group, the majority were from specimens collected from the skin and soft tissue system (24 out of 92, 26.1%). This was followed by musculoskeletal specimens (15 out of 92, 16.3%), and central nervous system specimens (14 out of 92, 15.2%). Pus samples had a positivity rate of 66.3% with 5 times higher odds of being positive compared to non-pus samples (25%). Overall, there were 260 identified organisms by 16S test of which the most detected organisms were Staphylococcus spp, Streptococcus spp. and Enterobacterales. The results revealed that 16S testing impacted management in 45.9% of the cases (83/181) showing a change in management. Antibiotic escalation was applied in 31.3% of cases (26/83). Antibiotic de-escalation occurred in 41% of cases (34/83). A change in the treating diagnosis was noted in 26.5% of cases (22/83).
Conclusion
Identification of pathogens using the 16S test in combination with conventional cultures is essential in clinical diagnostics and management of infectious diseases to provide targeted therapy and improve antimicrobial stewardship. Shorter turnaround time, improved patient management, and cost-effectiveness are key factors to consider when advocating for the broader adoption of 16S testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Infectious Diseases Research (CIDR) and World Health Organization (WHO) Collaborating Center for Reference and Research on Bacterial Pathogens, American University of Beirut, Beirut, Lebanon.
- Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
- Pediatric Infectious Diseases Division, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
- Department of Experimental Pathology, Immunology, and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
- Clinical Microbiology Laboratory, Department of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Zitieren
APA
Youssef, N., Boutros, C. F., Dakroub, F., Akl, F., Reslan, L., Finianos, M., Moumneh, M. B. M., Dargham, T. B., Zein, Z. E., Haddara, A., Korman, R., Khafaja, S., Matar, G., Araj, G. F., & Dbaibo, G. S. (2025). The clinical impact of 16S ribosomal RNA PCR and sequencing in the identification of bacterial infections: a 7-year report from a Lebanese tertiary care center. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1619640
Vancouver
Youssef N, Boutros CF, Dakroub F, Akl F, Reslan L, Finianos M, et al. The clinical impact of 16S ribosomal RNA PCR and sequencing in the identification of bacterial infections: a 7-year report from a Lebanese tertiary care center. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1619640
BibTeX
@article{Youssef2025,
author = {Youssef, Nour and Boutros, Celina F and Dakroub, Fatima and Akl, Fata and Reslan, Lina and Finianos, Marc and Moumneh, Mohammad Bahij M and Dargham, Tarek Bou and Zein, Zeinab El and Haddara, Amani and Korman, Rawan and Khafaja, Sarah and Matar, Ghassan and Araj, George F and Dbaibo, Ghassan S},
title = {The clinical impact of 16S ribosomal RNA PCR and sequencing in the identification of bacterial infections: a 7-year report from a Lebanese tertiary care center},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1619640}
}
EUVIMED